Artikler med mandater om offentlig tilgang - Scott McDonnellLes mer
Ikke tilgjengelig noe sted: 1
NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma
CA Murga-Zamalloa, V Mendoza-Reinoso, AA Sahasrabuddhe, ...
Oncogene 36 (15), 2085-2094, 2017
Mandater: US National Institutes of Health
Tilgjengelige et eller annet sted: 5
PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations
HY Zou, Q Li, LD Engstrom, M West, V Appleman, KA Wong, M McTigue, ...
Proceedings of the National Academy of Sciences 112 (11), 3493-3498, 2015
Mandater: US Department of Energy
The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis
LM McAllister-Lucas, X Jin, S Gu, K Siu, S McDonnell, J Ruland, ...
Journal of Biological Chemistry 285 (34), 25880-25884, 2010
Mandater: US National Institutes of Health
Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK–mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphoma
SRP McDonnell, SR Hwang, D Rolland, C Murga-Zamalloa, V Basrur, ...
Blood, The Journal of the American Society of Hematology 122 (6), 958-968, 2013
Mandater: US National Institutes of Health
NPM-ALK signals through glycogen synthase kinase 3β to promote oncogenesis
SRP McDonnell, SR Hwang, V Basrur, KP Conlon, D Fermin, E Wey, ...
Oncogene 31 (32), 3733-3740, 2012
Mandater: US National Institutes of Health
Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic …
SR Hwang, C Murga-Zamalloa, N Brown, J Basappa, SRP McDonnell, ...
Laboratory Investigation 97 (8), 962-970, 2017
Mandater: US National Institutes of Health
Informasjon om publisering og finansiering fastsettes automatisk av et datamaskinprogram